Yaky Yanay
2015
In 2015, Yaky Yanay earned a total compensation of $786.7K as Co, CEO and President at Pluristem Therapeutics, which was about the same as previous year.
Compensation breakdown
| Salary | $249,000 |
|---|---|
| Stock Awards | $512,000 |
| Other | $25,721 |
| Total | $786,721 |
Yanay received $512K in stock awards, accounting for 65% of the total pay in 2015.
Yanay also received $249K in salary and $25.7K in other compensation.
Rankings
In 2015, Yaky Yanay's compensation ranked 9,054th out of 13,638 executives tracked by ExecPay. In other words, Yanay earned more than 33.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,054 out of 13,638 | 34th |
Division Manufacturing | 3,453 out of 5,190 | 34th |
Major group Chemicals And Allied Products | 1,258 out of 1,854 | 32nd |
Industry group Drugs | 1,024 out of 1,528 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 179 out of 254 | 30th |
Source: SEC filing on April 3, 2018.
Yanay's colleagues
We found one more compensation record of an executive who worked with Yaky Yanay at Pluristem Therapeutics in 2015.
2015
Zami Aberman
Pluristem Therapeutics
Chief Executive Officer
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019